title: Anaphylaxis in the allergist's office: preparing your office and staff for medical emergencies.
abstract: All allergists who administer subcutaneous immunotherapy (SCIT) experience anaphylaxis in their offices and must devote proper planning, preparation, and practice to ensure that all staff members recognize the early signs and symptoms of anaphylaxis and can respond appropriately. Educating staff and patients, preparing an anaphylaxis emergency cart, developing and following selection criteria for SCIT and high-risk procedures, and customizing an "Action Plan for Anaphylaxis Management" create the foundation for mounting an adequate response to anaphylaxis. Strategies to prevent near-fatal and fatal reactions include (1) avoiding, when possible, the administration of SCIT to patients on beta-blockers; (2) using a preinjection questionnaire to review changes in the patient's medical condition, e.g., episodes of asthma since the previous injection; (3) using standardized forms and procedures for SCIT; (4) one might also consider an objective measure of airway function (e.g., peak flow measurement) for the asthmatic patient before allergy injections; (5) insisting on a 30-minute waiting time after SCIT; and (6) giving consideration to prescribing a dual-pack epinephrine autoinjector to all SCIT patients. Treatment of anaphylaxis should start with epinephrine administered intramuscularly at the first sign of anaphylaxis. Oxygen and i.v. fluids may be needed for moderate-to-severe anaphylaxis or anaphylaxis that is quickly developing or unresponsive to the first injection of epinephrine. Emergency medical services should be called for all patients who are experiencing moderate-to-severe (grade 2 or higher) anaphylaxis, if they require more than 1 dose of epinephrine and/or i.v. fluids, or if they do not immediately respond to treatment.
authors.affiliation: Department of Medicine, Nova Southeastern University, Davie, Florida, USA. drdanawallace@florida-allergy.com
authors.forename: Dana V
authors.initials: DV
authors.lastname: Wallace
mesh_terms: D000486:Allergy and Immunology / Q000295:instrumentation; D000707:Anaphylaxis / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D002985:Clinical Protocols; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D004630:Emergencies; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008503:Medical Staff / Q000193:education; D010824:Physicians' Offices / Q000458:organization & administration